NO20011263L - Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav - Google Patents

Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav

Info

Publication number
NO20011263L
NO20011263L NO20011263A NO20011263A NO20011263L NO 20011263 L NO20011263 L NO 20011263L NO 20011263 A NO20011263 A NO 20011263A NO 20011263 A NO20011263 A NO 20011263A NO 20011263 L NO20011263 L NO 20011263L
Authority
NO
Norway
Prior art keywords
immunogenic fragments
polypeptides
moraxella catarrhalis
basb034 polypeptides
basbo34
Prior art date
Application number
NO20011263A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011263D0 (no
Inventor
Jean-Louis Ruelle
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of NO20011263D0 publication Critical patent/NO20011263D0/no
Publication of NO20011263L publication Critical patent/NO20011263L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20011263A 1998-09-14 2001-03-13 Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav NO20011263L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9820002.5A GB9820002D0 (en) 1998-09-14 1998-09-14 Novel compounds
PCT/EP1999/006781 WO2000015802A1 (en) 1998-09-14 1999-09-14 Moraxella catarrhalis basb034 polypeptides and uses thereof

Publications (2)

Publication Number Publication Date
NO20011263D0 NO20011263D0 (no) 2001-03-13
NO20011263L true NO20011263L (no) 2001-04-30

Family

ID=10838841

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011263A NO20011263L (no) 1998-09-14 2001-03-13 Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav

Country Status (21)

Country Link
US (2) US6600013B1 (zh)
EP (1) EP1114160B1 (zh)
JP (1) JP2002525057A (zh)
KR (1) KR20010085794A (zh)
CN (1) CN1198931C (zh)
AT (1) ATE312923T1 (zh)
AU (1) AU752667B2 (zh)
BR (1) BR9914492A (zh)
CA (1) CA2342398A1 (zh)
CZ (1) CZ2001927A3 (zh)
DE (1) DE69928947T2 (zh)
ES (1) ES2253911T3 (zh)
GB (1) GB9820002D0 (zh)
HU (1) HUP0103945A3 (zh)
IL (1) IL141996A0 (zh)
NO (1) NO20011263L (zh)
NZ (1) NZ510512A (zh)
PL (1) PL347943A1 (zh)
TR (1) TR200100741T2 (zh)
WO (1) WO2000015802A1 (zh)
ZA (1) ZA200102108B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812163D0 (en) 1998-06-05 1998-08-05 Smithkline Beecham Biolog Novel compounds
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
KR101239242B1 (ko) 2002-08-02 2013-03-11 글락소스미스클라인 바이오로지칼즈 에스.에이. 항원 조합물을 포함하는 나이세리아 백신 조성물
AU2003298475A1 (en) * 2002-11-14 2004-06-18 Adherex Technologies, Inc. Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2274495C (en) * 1996-12-20 2009-06-02 Board Of Regents, The University Of Texas System Uspa1 and uspa2 antigens of moraxella catarrhalis
US6673910B1 (en) * 1999-04-08 2004-01-06 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics
EP1218512A2 (en) * 1999-06-18 2002-07-03 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins

Also Published As

Publication number Publication date
HUP0103945A3 (en) 2003-11-28
US6600013B1 (en) 2003-07-29
ZA200102108B (en) 2002-10-23
ES2253911T3 (es) 2006-06-01
NZ510512A (en) 2002-10-25
US20030180317A1 (en) 2003-09-25
CZ2001927A3 (cs) 2001-08-15
ATE312923T1 (de) 2005-12-15
PL347943A1 (en) 2002-04-22
NO20011263D0 (no) 2001-03-13
IL141996A0 (en) 2002-03-10
DE69928947T2 (de) 2006-06-29
US7432366B2 (en) 2008-10-07
CA2342398A1 (en) 2000-03-23
EP1114160B1 (en) 2005-12-14
TR200100741T2 (tr) 2001-09-21
WO2000015802A1 (en) 2000-03-23
EP1114160A1 (en) 2001-07-11
DE69928947D1 (de) 2006-01-19
HUP0103945A2 (hu) 2002-02-28
BR9914492A (pt) 2001-06-26
CN1326509A (zh) 2001-12-12
GB9820002D0 (en) 1998-11-04
AU5863299A (en) 2000-04-03
CN1198931C (zh) 2005-04-27
JP2002525057A (ja) 2002-08-13
AU752667B2 (en) 2002-09-26
KR20010085794A (ko) 2001-09-07

Similar Documents

Publication Publication Date Title
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
HUP9901186A2 (hu) Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
DE69838143D1 (de) Antimikrobielle peptide
GB9911683D0 (en) Antigenic peptides
DE60039050D1 (de) Antigene meningokokken peptide
EP2011510A3 (en) Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments
SG52480A1 (en) Immunogenic compositions against helicobacter infection polypeptides for use in the compositions and nucleic accid sequences encoding said polypeptides
EP1420821A4 (en) IMMUNOLOGICALLY IMPRESSIVE HERPES-SIMPLEX VIRUS ANTIGENS AND METHODS OF THEIR USE
EP0733071A4 (en) ANTAGONISTS OF CHAPERONINE 10
NO20011263L (no) Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
AU5776799A (en) Modified hcv peptide vaccines
ATE480554T1 (de) Rekombinanter leukotoxinimpfstoff aus fusobacterium necrophorum und dessen präparation
DE60036555D1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
NZ507983A (en) A polypeptide comprising the amino acid of an n- terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
DK0938329T3 (da) Immunogen TLP sammensætning
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
MY107451A (en) Cloning and expression of a rhoptry associated protein of p.falciparum
ZA896942B (en) Allelic variants of plasmodium falciparum merozoite surface antigen
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
GB2244273A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
GB2341606A (en) Glycosylation peptides
SE0002738D0 (sv) Electric actuator
RU2003130226A (ru) Применение белка uk114 или его фрагментов для лечения и предупреждения эндотоксического шока

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application